Annual General Meeting
April 16, 2012 | General Meetings
Ordinary General Meeting was held on Monday, 16 April 2012 at 16.00 o'clock
at Comwell Borupgaard, Nørrevej 80, 3070 Snekkersten, Denmark.
MENU
- About us
ABOUT US
Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
READ MORE - Pipeline
PIPELINE
Our pipeline comprises multiple product candidates which are subject to more than 20 ongoing clinical studies in infectious diseases and cancer. Many of our programs are supported by external funding through either private or governmental partnerships.
Read more - INVESTORS
INVESTORS
Bavarian Nordic is committed to providing our shareholders and the media with reliable and transparent information about our business, development programs and results in an open and timely manner
Read more - Careers
CAREERS
Bavarian Nordic offers a challenging international working environment in which
READ MORE
job satisfaction and personal growth have a high priority.